Ga68-Dolacga Injection

DRUG2 trials

Sponsors

National Atomic Research Institute, Taiwan

Conditions

Hepatic CarcinomaSafety Issues

Phase 1

to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers

CompletedNCT03908957

National Atomic Research Institute, TaiwanSafety Issues

Start: 2019-02-12End: 2019-08-09Updated: 2020-02-13

Phase 2

to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve

CompletedNCT05007548

National Atomic Research Institute, TaiwanHepatic Carcinoma

Start: 2021-12-14End: 2023-11-20Updated: 2023-12-13